f1 on june 13, 2007, the reporting person exercised 200 sars at $19.93 as reported on table ii which, at the closing price of$30.59 on that day, resulted in the 47 shares being issued to the reporting person and 23 shares being withheld for taxes,as reported on table i. f2 sars were granted at no cost to the reporting person.

f1 each restricted stock unit ("rsu") represents a contingent right to receive one share of common stock, par value $0.01 pershare of conmed corporation (the "company") and will be subject to the terms and conditions of the company's 2006 stockincentive plan, with the rsus generally vesting over a five year period with the first 20% of the rsu's vesting one yearafter the grant date. f3 the rsus and sars were granted at no cost to the reporting person.

f3 the rsus and sars were granted at no cost to the reporting person. f2 the stock appreciation rights ("sars") were granted under the company's 2006 stock incentive plan and generally vest in equalamounts over a five year period.

f1 each restricted stock unit ("rsu") represents a contingent right to receive one share of common stock, par value $0.01 pershare of conmed corporation (the "company") and will be subject to the terms and conditions of the company's 2006 stockincentive plan, with the rsus generally vesting over a five year period with the first 20% of the rsu's vesting one yearafter the grant date. f3 the rsus and sars were granted at no cost to the reporting person.